These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Functional correlation of ATP1A2 mutations with phenotypic spectrum: from pure hemiplegic migraine to its variant forms. Li Y; Tang W; Kang L; Kong S; Dong Z; Zhao D; Liu R; Yu S J Headache Pain; 2021 Aug; 22(1):92. PubMed ID: 34384358 [TBL] [Abstract][Full Text] [Related]
10. ATP1A3-related phenotypes in Chinese children: AHC, CAPOS, and RECA. Huang D; Song X; Ma J; Li X; Guo Y; Li M; Luo H; Fang Z; Yang C; Xie L; Jiang L Eur J Pediatr; 2023 Feb; 182(2):825-836. PubMed ID: 36484864 [TBL] [Abstract][Full Text] [Related]
11. Hereditary spastic paraplegia is a novel phenotype for germline de novo ATP1A1 mutation. Stregapede F; Travaglini L; Rebelo AP; Cintra VP; Bellacchio E; Bosco L; Alfieri P; Pro S; Zuchner S; Bertini E; Nicita F Clin Genet; 2020 Mar; 97(3):521-526. PubMed ID: 31705535 [TBL] [Abstract][Full Text] [Related]
12. Biallelic loss of function variants in ATP1A2 cause hydrops fetalis, microcephaly, arthrogryposis and extensive cortical malformations. Monteiro FP; Curry CJ; Hevner R; Elliott S; Fisher JH; Turocy J; Dobyns WB; Costa LA; Freitas E; Kitajima JP; Kok F Eur J Med Genet; 2020 Jan; 63(1):103624. PubMed ID: 30690204 [TBL] [Abstract][Full Text] [Related]
13. De novo exonic duplication of ATP1A2 in Italian patient with hemiplegic migraine: a case report. Gagliardi S; Grieco GS; Gualandi F; Caniatti LM; Groppo E; Valente M; Nappi G; Neri M; Cereda C J Headache Pain; 2017 Dec; 18(1):63. PubMed ID: 28593511 [TBL] [Abstract][Full Text] [Related]
14. ATP1A1-linked diseases require a malfunctioning protein product from one allele. Spontarelli K; Young VC; Sweazey R; Padro A; Lee J; Bueso T; Hernandez RM; Kim J; Katz A; Rossignol F; Turner C; Wilczewski CM; Maxwell GL; Holmgren M; Bailoo JD; Yano ST; Artigas P Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119572. PubMed ID: 37659504 [TBL] [Abstract][Full Text] [Related]
15. A novel de novo nonsense mutation in ATP1A2 associated with sporadic hemiplegic migraine and epileptic seizures. Gallanti A; Tonelli A; Cardin V; Bussone G; Bresolin N; Bassi MT J Neurol Sci; 2008 Oct; 273(1-2):123-6. PubMed ID: 18644608 [TBL] [Abstract][Full Text] [Related]
16. ATP2B2 de novo variants as a cause of variable neurodevelopmental disorders that feature dystonia, ataxia, intellectual disability, behavioral symptoms, and seizures. Poggio E; Barazzuol L; Salmaso A; Milani C; Deligiannopoulou A; Cazorla ÁG; Jang SS; Juliá-Palacios N; Keren B; Kopajtich R; Lynch SA; Mignot C; Moorwood C; Neuhofer C; Nigro V; Oostra A; Prokisch H; Saillour V; Schuermans N; Torella A; Verloo P; Yazbeck E; Zollino M; Jech R; Winkelmann J; Necpal J; Calì T; Brini M; Zech M Genet Med; 2023 Dec; 25(12):100971. PubMed ID: 37675773 [TBL] [Abstract][Full Text] [Related]
17. The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: A clinical and genetic study in Finnish migraine families. Hiekkala ME; Vuola P; Artto V; Häppölä P; Häppölä E; Vepsäläinen S; Cuenca-León E; Lal D; Gormley P; Hämäläinen E; Ilmavirta M; Nissilä M; Säkö E; Sumelahti ML; Harno H; Havanka H; Keski-Säntti P; Färkkilä M; Palotie A; Wessman M; Kaunisto MA; Kallela M Cephalalgia; 2018 Oct; 38(12):1849-1863. PubMed ID: 29486580 [TBL] [Abstract][Full Text] [Related]
18. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome. Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258 [TBL] [Abstract][Full Text] [Related]
19. Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2. Lassuthova P; Rebelo AP; Ravenscroft G; Lamont PJ; Davis MR; Manganelli F; Feely SM; Bacon C; Brožková DŠ; Haberlova J; Mazanec R; Tao F; Saghira C; Abreu L; Courel S; Powell E; Buglo E; Bis DM; Baxter MF; Ong RW; Marns L; Lee YC; Bai Y; Isom DG; Barro-Soria R; Chung KW; Scherer SS; Larsson HP; Laing NG; Choi BO; Seeman P; Shy ME; Santoro L; Zuchner S Am J Hum Genet; 2018 Mar; 102(3):505-514. PubMed ID: 29499166 [TBL] [Abstract][Full Text] [Related]
20. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. De Fusco M; Marconi R; Silvestri L; Atorino L; Rampoldi L; Morgante L; Ballabio A; Aridon P; Casari G Nat Genet; 2003 Feb; 33(2):192-6. PubMed ID: 12539047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]